4-(3-(4-cyano-3-(trifluoromethyl)phenyl)-5,5-dimethyl-4-oxo-2-thioxoimidazolidin-1-yl)benzoic acid

Brivaracetam impurity 155

(E)-(3aR,4aR,6R,8aR,9aR)-8a-methyl-3,5-dimethylene-2-oxododecahydronaphtho[2,3-b]furan-6-yl 3-(pyridin-4-yl)acrylate

(R)-(3aR,4aR,6R,8aR,9aR)-8a-methyl-3,5-dimethylene-2-oxododecahydronaphtho[2,3-b]furan-6-yl 4,4-difluoropyrrolidine-2-carboxylate

(R)-(3aR,4aR,6R,8aR,9aR)-8a-methyl-3,5-dimethylene-2-oxododecahydronaphtho[2,3-b]furan-6-yl 5-azaspiro[2.4]heptane-6-carboxylate

(R)-5-tert-butyl 6-((3aR,4aR,6R,8aR,9aR)-8a-methyl-3,5-dimethylene-2-oxododecahydronaphtho[2,3-b]furan-6-yl) 5-azaspiro[2.4]heptane-5,6-dicarboxylate

(3aR,4aR,6R,8aR,9aR)-8a-methyl-3,5-dimethylene-2-oxododecahydronaphtho[2,3-b]furan-6-yl furan-2-carboxylate

1'-nitroso-1,4'-bipiperidine

3-(2-fluoro-2-(3-isobutylpyridin-4-yl)ethyl)(pentafluoromercapto)benzene

(7R,14R)-1-(difluoromethoxy)-11-((R)-4-ethyl-4-hydroxy-3,4-dihydro-2H-pyrano[3,2-b]pyridin-7-yl)-6-methyl-6,7-dihydro-7,14-methanobenzo[f]benzo[4,5]imidazo[1,2-a][1,4]diazocin-5(14H)-one

(7R,14R)-11-((2R,4R)-4-amino-2-methyl-3,4-dihydro-2H-pyrano[3,2-b]pyridin-7-yl)-1-(difluoromethoxy)-6-methyl-6,7-dihydro-7,14-methanobenzo[f]benzo[4,5]imidazo[1,2-a][1,4]diazocin-5(14H)-one

4,4,9,9-Tetrahexyl-4,9-dihydro-2,7-bis(trimethylstannyl)benzo[1′′,2′′:4,5;4′′,5′′:4′,5′]bissilolo[3,2-b:3′,2′-b′]dithiophene

Sulfur diimide, (1,1-dimethylethyl)(tributylstannyl)-, (E,Z)-

3-[[4-[2′,2′,7′,7′-Tetraoctyl-3′-(tributylstannyl)[1,1′-bispiro[4H-cyclopenta[c]thiophene-5(6H),9′-[9H]fluoren]]-3-yl]phenyl]thio]propanenitrile

1,1′-[5,5,12,12-Tetrakis(4-hexylphenyl)-5,12-dihydrobisthieno[2′,3′:4,5]thieno[2,3-d:2′,3′-d′]-s-indaceno[1,2-b:5,6-b′]dithiophene-2,9-diyl]bis[1,1,1-trimethylstannane]